Trials / Conditions / Adult B Acute Lymphoblastic Leukemia

Adult B Acute Lymphoblastic Leukemia

13 registered clinical trials studyying Adult B Acute Lymphoblastic Leukemia.

Status	Trial	Sponsor	Phase
Unknown	Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation NCT04626726	Hebei Senlang Biotechnology Inc., Ltd.	EARLY_Phase 1
Completed	Ibrutinib and Blinatumomab in Treating Patients With Relapsed or Refractory B Acute Lymphoblastic Leukemia NCT02997761	University of California, Davis	Phase 2
Terminated	Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection NCT02109224	National Cancer Institute (NCI)	Phase 1
Terminated	Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia NCT02129062	National Cancer Institute (NCI)	Phase 2
Terminated	Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic NCT01408160	Albert Einstein College of Medicine	Phase 1
Completed	Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-C NCT01567709	National Cancer Institute (NCI)	Phase 1
Completed	Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma NCT01326702	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Veliparib and Temozolomide in Treating Patients With Acute Leukemia NCT01139970	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblas NCT00792948	National Cancer Institute (NCI)	Phase 2
Completed	Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Ly NCT00866307	Children's Oncology Group	Phase 1
Completed	Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surg NCT00608361	National Cancer Institute (NCI)	Phase 1
Completed	Calaspargase Pegol or Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagno NCT00671034	Children's Oncology Group	Phase 3
Completed	Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin Du NCT00075725	Children's Oncology Group	Phase 3